Unlike those studies reporting the positive role of FMNL2 in several cancers, our results illustrated that FMNL2 silencing promoted cell migration and invasion of breast cancer in vitro and in vivo, suggesting that FMNL2 may function as a negative regulator of breast cancer migration and invasion. Here, FMNL2 is linked to cancer.